104 related articles for article (PubMed ID: 10698554)
1. Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays.
Sadick MD; Intintoli A; Quarmby V; McCoy A; Canova-Davis E; Ling V
J Pharm Biomed Anal; 1999 May; 19(6):883-91. PubMed ID: 10698554
[TBL] [Abstract][Full Text] [Related]
2. Kinase Receptor Activation (KIRA): a rapid and accurate alternative to endpoint bioassays.
Sadick MD
Dev Biol Stand; 1999; 97():121-33. PubMed ID: 10463538
[TBL] [Abstract][Full Text] [Related]
3. Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay.
Sadick MD; Galloway A; Shelton D; Hale V; Weck S; Anicetti V; Wong WL
Exp Cell Res; 1997 Aug; 234(2):354-61. PubMed ID: 9260905
[TBL] [Abstract][Full Text] [Related]
4. Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assay.
Sadick MD; Sliwkowski MX; Nuijens A; Bald L; Chiang N; Lofgren JA; Wong WL
Anal Biochem; 1996 Mar; 235(2):207-14. PubMed ID: 8833330
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor I: pros and cons of a bioassay.
Janssen JA
Horm Res Paediatr; 2011; 76 Suppl 1():106-10. PubMed ID: 21778760
[TBL] [Abstract][Full Text] [Related]
6. Development of a STAT5 phosphorylation assay as a rapid bioassay to assess interleukin-7 potency.
Zumpe C; Engel K; Wiedemann N; Metzger AU; Pischetsrieder M; Bachmann CL
Curr Pharm Biotechnol; 2011 Oct; 12(10):1580-8. PubMed ID: 21542800
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the GH/IGF-axis components: lessons from human studies.
Frystyk J
Domest Anim Endocrinol; 2012 Aug; 43(2):186-97. PubMed ID: 22153974
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
[TBL] [Abstract][Full Text] [Related]
9. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.
Chen JW; Ledet T; Orskov H; Jessen N; Lund S; Whittaker J; De Meyts P; Larsen MB; Christiansen JS; Frystyk J
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1149-55. PubMed ID: 12604504
[TBL] [Abstract][Full Text] [Related]
10. The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth.
Ashcroft M; Stephens RM; Hallberg B; Downward J; Kaplan DR
Oncogene; 1999 Aug; 18(32):4586-97. PubMed ID: 10467403
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease.
Janssen JAMJL; Varewijck AJ; Brugts MP
Growth Horm IGF Res; 2019; 48-49():16-28. PubMed ID: 31493625
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of standard and state of the art analytical technology-bioassays.
Indelicato SR; Bradshaw SL; Chapman JW; Weiner SH
Dev Biol (Basel); 2005; 122():103-14. PubMed ID: 16375255
[TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors.
Foehr ED; Tatavos A; Tanabe E; Raffioni S; Goetz S; Dimarco E; De Luca M; Bradshaw RA
FASEB J; 2000 May; 14(7):973-81. PubMed ID: 10783152
[TBL] [Abstract][Full Text] [Related]
14. Quantitative, high-throughput cell-based assays for inhibitors of trkA receptor.
Angeles TS; Lippy JS; Yang SX
Anal Biochem; 2000 Feb; 278(2):93-8. PubMed ID: 10660449
[TBL] [Abstract][Full Text] [Related]
15. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays.
Brugts MP; Ranke MB; Hofland LJ; van der Wansem K; Weber K; Frystyk J; Lamberts SW; Janssen JA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2539-45. PubMed ID: 18397983
[TBL] [Abstract][Full Text] [Related]
16. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
[TBL] [Abstract][Full Text] [Related]
17. Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis.
Jiang H; Movsesyan V; Fink DW; Fasler M; Whalin M; Katagiri Y; Monshipouri M; Dickens G; Lelkes PI; Guroff G; Lazarovici P
J Cell Biochem; 1997 Aug; 66(2):229-44. PubMed ID: 9213224
[TBL] [Abstract][Full Text] [Related]
18. The Src homology 2 domain protein Shb transmits basic fibroblast growth factor- and nerve growth factor-dependent differentiation signals in PC12 cells.
Karlsson T; Kullander K; Welsh M
Cell Growth Differ; 1998 Sep; 9(9):757-66. PubMed ID: 9751119
[TBL] [Abstract][Full Text] [Related]
19. Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs.
Okajima T; Nakamura K; Zhang H; Ling N; Tanabe T; Yasuda T; Rosenfeld RG
Endocrinology; 1992 Apr; 130(4):2201-212. PubMed ID: 1372238
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity.
Angeles TS; Steffler C; Bartlett BA; Hudkins RL; Stephens RM; Kaplan DR; Dionne CA
Anal Biochem; 1996 Apr; 236(1):49-55. PubMed ID: 8619495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
